The ABA's Section of Litigation has organized what should be an interesting program on "Pleading and Proving Loss Causation in Securities Class Actions Post Dura Pharmaceuticals."  A panel consisting of plaintiffs' counsel, defense counsel and a damages expert will cover subjects including:

• How must loss causation be pled in order to meet the standard?
• Must a specific corrective disclosure that causes a stock drop be alleged?
• Does the Dura decision encourage issuers to delay or bury harmful disclosures in order to make proof of loss causation more difficult?
• How does the decision affect the calculation of damages?

Considering that I've been "answering" all the loss causation questions sent my way by reporters by saying "I have no idea, call Lyle Roberts," I think I probably need to sign myself up!